Advertisement
open access
Medical Conferences
Conference Reports
Conference Proceedings
Disease Areas
Medical News
Multimedia
Podcast Channel
Videos
Webinar
About
2024 Medicom Conference Planning
Conference Proceedings
Home
>
Gastroenterology
>
ECCO 2021
ECCO 2021
European Crohn's and Colitis Organisation
2–3 July & 8–10 July 2021
Table of Contents
Colophon
Table of Contents
Featured articles
ECCO 2021 Highlights Podcast
Presented By
Dr Rachel Giles, Medicom
Biologics Updates
Similar efficacy of ustekinumab and adalimumab for moderate-to-severe CD
Presented By
Dr Peter Irving, Guy’s and St. Thomas’ Hospital, UK
Ustekinumab safe and effective in elderly CD patients
Presented By
Dr Diego Casas Deza, Hospital Universitario Miguel Servet
Early clinical remission and response following risankizumab therapy in CD
Presented By
Dr Stefan Schreiber, University Hospital Schleswig-Holstein, Germany
Risk of hospitalisation and surgery linked to IBD biological
Presented By
Dr Camilla Bjørn Jensen, Frederiksberg Hospital
Obesity increases the risk of immunogenicity to adalimumab in IBD
Presented By
Dr Remi Mahmoud, University Medical Centre Utrecht, the Netherlands
Improvements in Small Molecules
Upadacitinib meets primary endpoint for moderate-to-severe UC
Presented By
Dr Séverine Vermeire, University hospital Leuven, Belgium
Promising safety and pharmacokinetic data on BT051 for UC
Presented By
Dr Chris Stevens, Bacainn Therapeutics, Clinical Development, Concord, United States
Surgical closure plus anti-TNF outperforms anti-TNF alone for perianal fistula
Presented By
Ms Elise Meima-van Praag , Amsterdam University Medical Centre, the Netherlands
Novel Biomarkers
Blood proteins predicting relapse in CD identified
Presented By
Mr Nicolas Pierre, University of Liège, Belgium
Extracellular RNA has potential as a non-invasive biomarker in IBD
Presented By
Dr Bram Verstockt , University Hospital Leuven, Belgium
Risk Mitigation
No increased risk of (severe) COVID-19 among IBD patients
Presented By
Dr Vered Richter , Tel Aviv University, Israel
Oral faecal microbiota transplant therapy efficacious in UC
Presented By
Dr Craig Haifer, University of Sydney, Australia
Artificial intelligence outperforms human classifying of endoscopic images in UC
Presented By
Dr Bobby Lo , Hvidovre Hospital, Denmark
Increased risk of rectal cancer after colectomy in IBD
Presented By
Dr Elena Akimenko, Gentofte Hospital, Denmark
Risk of colorectal cancer is detected by low-pass whole genome sequencing
Presented By
Dr Ibrahim Al Bakir, Queen Mary University of London, UK
Large variability in IBD care and education across Europe
Presented By
Dr Jan Král, Institute for Clinical and Experimental Medicine, Czech Republic
Ultra-processed food intake associated with IBD
Presented By
Dr Neeraj Narula , McMaster University, UK
Factors of coping difficulties in IBD revealed
Presented By
Mr J. Marshall, University of Sheffield, Academic Unit of Primary Medical Care, Sheffield, United Kingdom